Latest news
Stay up to date on the latest activities and publications from hera
Archive
- 2023
- 2024
- 2025
- Aarti Patel
- Accountability
- Afghanistan
- Africa
- Alejandra Martinez
- Algeria
- Alice Behrendt
- Alice Peschiutta
- Angola
- Anne Buve
- Argentina
- Asia Pacific
- Assessment
- Bangladesh
- Basic Health Services / Primary health care
- Behaviour Change Communication
- Belize
- Benin (Dahomey)
- Botswana
- Cabo Verde
- Calvin Tonga
- Caribbean
- Central Asia
- Chad
- Child Protection
- Children
- Cholera
- Climate change
- Communicable diseases (CD)
- Community Engagement
- Community Health Workers
- Comoros
- Costing studies
- Country Capacity
- Covid-19
- Crisis Management
- Côte d'Ivoire
- DRC
- Demand side financing
- Development
- Development Cooperation
- Dia Timmermans
- Dijbouti
- Drug Pricing
- Drug Regulatory Authority
- Ecuador
- Ed Vreeke
Strengthening access to reproductive health commodities: hera’s evaluation of the Best Practices Grant
From 2020 to 2025, the Clinton Health Access Initiative (CHAI), with funding from the UK’s Foreign, Commonwealth & Development Office (FCDO), led a programme entitled “Establishing Best Practices for Government-Led Product Introductions” (referred to as the Best Practices Grant)—an ambitious £40 million initiative aimed at improving access to Reproductive Health (RH) commodities across several low- and middle-income countries.
hera was contracted by CHAI to conduct the final external evaluation of the BPG, with a mandate to capture lessons, assess results, and generate insights to inform both the FCDO’s final Programme Completion Review and future investments in RH market shaping.
Pioneering health sector reform: Rwanda's National Pharmacy Policy (2024-2029)
In a milestone achievement for global health policy, Rwanda has successfully launched its National Pharmacy Policy (2024-2029), marking a transformative step toward strengthening pharmaceutical governance and aligning with the country’s ambitious Vision 2050 goals. This comprehensive policy, developed by hera through a participatory and evidence-based process, not only addresses systemic gaps in the pharmaceutical sector but also positions Rwanda as a regional leader in innovative and inclusive health reforms.